Want to see CCCC full AI Analyst Report?
C4 Therapeutics (CCCC) Stock Forecast & Price Target
CCCC Analyst Ratings
CCCC Stock 12 Month Forecast
Average Price Target
$9.00▲(167.06% Upside)Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| Chad Messer | Lake Street | $11 | buy | 226.41%Upside | Initiated | 10/28/26 | ||
 Unknown AnalystNot Ranked | Guggenheim | $7 | buy | 107.72%Upside | Initiated | 10/21/26 | ||
| Anupam Rama | J.P. Morgan | $10 | buy | 196.74%Upside | Initiated | 10/09/26 | ||
| Etzer Darout | Barclays | $7 | buy | 107.72%Upside | Reiterated | 08/12/26 | ||
| Derek Archila | Wells Fargo | $10 | buy | 196.74%Upside | Assigned | 08/12/26 | ||
| Tyler Van Buren | TD Cowen | ― | buy | ― | Reiterated | 08/11/26 | ||
| Akash Tewari | Jefferies | $14 | buy | 315.43%Upside | Reiterated | 04/30/26 | ||
| Leah R. Cann | Brookline Capital Markets | $20→$30 | buy | 790.21%Upside | Reiterated | 02/23/26 | ||
| Unknown AnalystNot Ranked | Evercore ISI | $7 | buy | 107.72%Upside | Reiterated | 12/18/25 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Chad Messer | 10/28/26 | $11 | buy | 226.41%Upside | Initiated | Lake Street | ||
| Unknown AnalystNot Ranked | 10/21/26 | $7 | buy | 107.72%Upside | Initiated | Guggenheim | ||
| Anupam Rama | 10/09/26 | $10 | buy | 196.74%Upside | Initiated | J.P. Morgan | ||
| Etzer Darout | 08/12/26 | $7 | buy | 107.72%Upside | Reiterated | Barclays | ||
| Derek Archila | 08/12/26 | $10 | buy | 196.74%Upside | Assigned | Wells Fargo | ||
| Tyler Van Buren | 08/11/26 | ― | buy | ― | Reiterated | TD Cowen | ||
| Akash Tewari | 04/30/26 | $14 | buy | 315.43%Upside | Reiterated | Jefferies | ||
| Leah R. Cann | 02/23/26 | $20→$30 | buy | 790.21%Upside | Reiterated | Brookline Capital Markets | ||
| Unknown AnalystNot Ranked | 12/18/25 | $7 | buy | 107.72%Upside | Reiterated | Evercore ISI |
Best Analysts Covering C4 Therapeutics
Copying Etzer Darout's trades and holding each position for 3 Months would result in 39.13% of your transactions generating a profit, with an average return of +17.27% per trade.
Copying Etzer Darout's trades and holding each position for 1 Year would result in 34.78% of your transactions generating a profit, with an average return of -5.81% per trade.
Copying Bradley Canino's trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -29.48% per trade.
CCCC Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 7 | 5 | 5 | 2 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 8 | 6 | 6 | 3 | 6 |
In the current month, CCCC has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CCCC average Analyst price target in the past 3 months is 9.00.
CCCC Financial Forecast
CCCC Sales Forecast
Next quarter’s sales forecast for CCCC is $0 with a range of ― to ―. The previous quarter’s sales results were $6.64M. CCCC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CCCC has Performed in-line its overall industry.